损坏的cAMP-PKA-CREB1信号驱动在癌症缓解症期间骨肌中的线粒体功能障碍
Elia Angelino1,2, Lorenza Bodo3, Roberta Sartori4,5
1Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Turin, Turin, Italy. elia.angelino@unito.it.
癌症缓解症通过损害cAMP-PKA-CREB1信号,导致线粒体功能障碍,导致肌肉消耗. 抑制基化酶4 (PDE4) 恢复了这种途径,保持了肌肉健康.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 生理学 生理学 生理学
背景情况:
- 骨肌肉消耗是癌症缓解症的标志,严重影响患者的结果.
- 线粒体功能障碍与肌肉消耗有关,但其在癌症中的上游原因尚不清楚.
研究的目的:
- 为了阐明导致癌症相关的骨肌肉衰竭中的线粒体功能障碍的分子机制.
- 确定潜在的治疗点,以抵消癌症缓解症中的肌肉消耗.
主要方法:
- 研究了cAMP依赖蛋白激酶A (PKA) 和CREB1在小鼠瘤诱导的肌肉衰竭中的作用.
- 利用基化酶4 (PDE4) 的药理抑制来恢复cAMP-PKA-CREB1信号传递.
- 评估了线粒体基因表达,线粒体功能和骨肌肉质量.
主要成果:
- 癌症抑制了骨肌中的cAMP-PKA-CREB1信号,降低了线粒体完整性基因的调节.
- 抑制PDE4挽救了线粒体基因表达和功能.
- 在雄性小鼠中,药理性地恢复cAMP-PKA-CREB1信号减轻了骨肌肉衰竭.
结论:
- 瘤诱导的cAMP-PKA-CREB1轴的抑制是癌症缓解症中线粒体功能障碍的关键机制.
- 准PDE4,特别是PDE4D,提供了一种潜在的治疗策略,以保护肌肉线粒体功能并对抗衰竭.
更多相关视频
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
08:12Author Spotlight: Unveiling Mitochondrial Function and Cellular Metabolic Adaptation in Metabolic Diseases
Published on: October 4, 2024
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
